arrow
M

Manuel Ramos-Casals

Department of Autoimmune Diseases
H指数:95
被引数:3.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

2023 International Rome consensus for the nomenclature of Sjögren disease

关于舍格伦病命名的2023国际罗马共识

2025-06-100
PREAI
Temporal relationship between sarcoidosis and malignancies in a nationwide cohort of 1942 patients
2024-07-082
PRE
OFF-LABEL USE OF BIOLOGICS AND SMALL MOLECULES IN SJÖGREN DISEASE: REAL-WORLD DATA FROM THE INTERNATIONAL SJÖGREN BIG DATA COHORT

生物制剂和小分子在舍格伦综合征中的超说明书用药:国际舍格伦大数据队列的真实世界数据

2024-06-010
PRE
Mortality risk factors in primary Sjogren syndrome: a real-world, retrospective, cohort study
2023-07-0110
OAAI
Characterisation of the coexistence between sarcoidosis and Sjogren's syndrome. Analysis of 43 patients
2022-12-202
OA
Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine

在羟氯喹的系统性红斑狼疮患者的跨国初始队列中的视网膜毒性

2022-11-179
OAAI
Prediction of Hospitalizations in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index

使用系统性红斑狼疮国际合作诊所脆弱指数预测系统性红斑狼疮的住院治疗

2022-02-1715
OAAI
Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients
2021-12-0122
OAAI
Immune checkpoint inhibitore-associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuation
2021-11-0135
OAAI
Cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and Medications

大型初始系统性红斑狼疮队列的癌症风险: 人口统计学特征,吸烟和药物的影响

2021-10-1218
OAAI
Clinical characterization and outcomes of 85 patients with neurosarcoidosis
2021-07-0221
OAAI